| 1 |
Bosoteanu M, Deacu M, Voda RI, Orasanu CI, Aschie M, Vlad SE, Penciu RC, Chirila SI. Five-Year Retrospective Study of Uterine STUMP and Leiomyosarcoma. Clin Pract 2022;12:897-907. [PMID: 36412673 DOI: 10.3390/clinpract12060094] [Reference Citation Analysis]
|
| 2 |
Liu H, Wong C, Wong C, Liu F. Uterine smooth muscle tumor of uncertain malignant potential: A review of current knowledge. Taiwanese Journal of Obstetrics and Gynecology 2022;61:935-940. [DOI: 10.1016/j.tjog.2022.08.003] [Reference Citation Analysis]
|
| 3 |
Guo E, Li C, Hu Y, Zhao K, Zheng Q, Wang L. Leiomyoma with Bizarre Nuclei: A Current Update. IJWH 2022;Volume 14:1641-1656. [DOI: 10.2147/ijwh.s388278] [Reference Citation Analysis]
|
| 4 |
Sparić R, Andjić M, Babović I, Nejković L, Mitrović M, Štulić J, Pupovac M, Tinelli A. Molecular Insights in Uterine Leiomyosarcoma: A Systematic Review. IJMS 2022;23:9728. [DOI: 10.3390/ijms23179728] [Reference Citation Analysis]
|
| 5 |
Záveský L, Jandáková E, Weinberger V, Minář L, Hanzíková V, Dušková D, Faridová A, Turyna R, Slanař O, Hořínek A, Kohoutová M. Small non-coding RNA profiling in breast cancer: plasma U6 snRNA, miR-451a and miR-548b-5p as novel diagnostic and prognostic biomarkers. Mol Biol Rep 2022;49:1955-71. [PMID: 34993725 DOI: 10.1007/s11033-021-07010-8] [Reference Citation Analysis]
|
| 6 |
Dundr P, Gregová M, Hojný J, Krkavcová E, Michálková R, Němejcová K, Bártů M, Hájková N, Laco J, Mára M, Richtárová A, Zima T, Stružinská I. Uterine cellular leiomyomas are characterized by common HMGA2 aberrations, followed by chromosome 1p deletion and MED12 mutation: morphological, molecular, and immunohistochemical study of 52 cases. Virchows Arch 2021. [PMID: 34626221 DOI: 10.1007/s00428-021-03217-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Tossamartvorakul M, Mendoza MCVR, Huang KG, Chang SH. Metastatic Smooth Muscle Tumor of Uncertain Malignant Potential after Laparoscopic Presuming Myomectomy. Gynecol Minim Invasive Ther 2021;10:187-90. [PMID: 34485068 DOI: 10.4103/GMIT.GMIT_44_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Ning C, Zhang L, Zhao C, Chen X, Liu X, Gu C. Clinical and reproductive outcomes of uterine smooth muscle tumor of uncertain malignant potential: a single-center retrospective study. J Int Med Res 2021;49:3000605211008065. [PMID: 33884911 DOI: 10.1177/03000605211008065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Wei J, Purdy J. Uterine Mesenchymal Neoplasia. Practical Gynecologic Pathology 2021. [DOI: 10.1007/978-3-030-68608-6_6] [Reference Citation Analysis]
|
| 10 |
Hirsch MS, Watkins J. A Comprehensive Review of Biomarker Use in the Gynecologic Tract Including Differential Diagnoses and Diagnostic Pitfalls. Adv Anat Pathol 2020;27:164-92. [PMID: 31149908 DOI: 10.1097/PAP.0000000000000238] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 11 |
Howitt BE, Nucci MR. Uterine Mesenchymal Lesions. Gynecologic and Obstetric Pathology, Volume 2 2019. [DOI: 10.1007/978-981-13-3019-3_1] [Reference Citation Analysis]
|
